Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2023 Earnings Call Transcript

Matthew Scalo: Okay. Good afternoon, and welcome to the Myriad Genetics' First Quarter 2023 Earnings Call. During the call, we will review the financial results we released today.

Related Keywords

California ,United States ,South San Francisco ,Salt Lake City ,Utah ,Salt Lake ,America ,Matthew Scalo ,Mark Verratti ,Mason Carrico ,Puneet Souda ,Nicole Lambert ,Paul Diaz ,Walter Gilbert ,Bryan Riggsbee ,Andrew Cooper ,Mychoice Cdx ,Dave Delahunt ,Jack Meehan ,Raymond James ,Matt Scalo ,Exchange Commission ,Nephron Research ,Goldman Sachs ,Innovation Center ,Genetics Inc ,Nasdaq ,Walter Gilbert Research ,Myriad Genetics ,Call Transcript May ,Myriad Genetic First Quarter ,Senior Vice President ,Chief Executive Officer ,Chief Financial Officer ,Chief Operating Officer ,Chief Commercial ,Simonmed Imaging ,Chief Commercial Officer ,Net Promoter Score ,Gateway Genomics ,Precise Tumor ,Nobel Prize ,Investor Relations ,Myriad Genetics Inc ,Derik De Bruin ,